In the interview given to BX1, our co-director, Michel Goldman, talks about the progress made in the fight against COVID-19, the unprecedented acceleration of the research process and possible issues with the production of sufficient quantities of the vaccine.
How to prevent and cure COVID-19?
Watch the recording of our conference-debate on the vaccines and immunotherapies at the forefront of the fight against the pandemic.
Given the limitations of existing drugs and the uncertainty regarding vaccines, the world must also focus on developing new weapons to target the SARS-CoV-2 virus that causes COVID-19. Besides anti-viral chemical drugs, genetically engineered antibodies might be ideal for this purpose.
Read the article published in Project Syndicate by Michel Kazatchkine and our co-director, Michel Goldman, where they call for more funds to be allocated towards the research on antibody treatments.